ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership120,877 shares
Latest Disclosed Value $ 2,690,722
Caption Management, LLC ownership in ACAD / ACADIA Pharmaceuticals Inc.

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 120,877 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $2,690,722 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of ACADIA Pharmaceuticals Inc.. The current value of the position is $2,590,394 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (ACAD) in the form of stock options. The firm currently holds call options representing 180,000 of underlying shares valued at $4,006,800 USD and put options representing 220,000 of underlying shares valued at $4,897,200 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ACAD / ACADIA Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 120,877 120,877 2,691 0.0157
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -8,455 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 8,455 -56,769 -87.04 182 -83.19 0.0020
2025-05-15 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 65,224 65,224 1,083 0.0104
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -7,800 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 7,800 -58,800 -88.29 127 -89.76 0.0020
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 66,600 66,600 1,231 0.0187
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -1,766 -100.00 0 -100.00
2022-08-15 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,766 -17,034 -90.61 25 -94.51 0.0003
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 18,800 18,800 455 0.0055
2022-02-11 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -21,500 -100.00 0 -100.00
2021-11-12 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 21,500 -35,500 -62.28 357 -74.32 0.0041
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 57,000 -54,700 -48.97 1,390 -51.77 0.0181
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 111,700 51,100 84.32 2,882 -10.99 0.0620
2021-02-16 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 60,600 25,600 73.14 3,238 124.24 0.0738
2020-11-16 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 35,000 -15,457 -30.63 1,444 -40.96 0.0338
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 50,457 50,457 44.16 2,446 69.39 0.0815
2020-05-14 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -20,700 -100.00 0 -100.00
2020-02-13 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,700 -4,300 -17.20 885 -1.56 0.0297
2019-11-14 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 25,000 25,000 20.77 899 1.58 0.0468
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -36,000 -100.00 0 -100.00
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 36,000 36,000 549 0.0425
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM Call 180,000 80.00 4,007 49.98 n/a n/a n/a
2026-02-17 2025-12-31 13F ACADIA PHARMACEUTICALS COM Call 100,000 -84.22 2,671 -80.25 n/a n/a n/a
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM Call 633,800 2,012.67 13,525 1,990.42 n/a n/a n/a
2025-08-14 2025-06-30 13F ACADIA PHARMACEUTICALS COM Call 30,000 647 n/a n/a n/a
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM Call 60,000 100.00 923 89.32 n/a n/a n/a
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM Call 30,000 -93.51 488 -94.30 n/a n/a n/a
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM Call 462,200 1,748.80 8,546 992.84 n/a n/a n/a
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM Call 25,000 -79.59 783 -69.36 n/a n/a n/a
2023-11-14 2023-09-30 13F ACADIA PHARMACEUTICALS COM Call 122,500 345.45 2,553 287.84 n/a n/a n/a
2023-08-14 2023-06-30 13F ACADIA PHARMACEUTICALS COM Call 27,500 659 n/a n/a n/a
2023-02-14 2022-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM Call 45,000 -83.89 738 -81.25 n/a n/a n/a
2022-08-15 2022-06-30 13F ACADIA PHARMACEUTICALS COM Call 279,400 26.08 3,937 -26.64 n/a n/a n/a
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM Call 221,600 5.02 5,367 8.97 n/a n/a n/a
2022-02-11 2021-12-31 13F ACADIA PHARMACEUTICALS COM Call 211,000 4,925 n/a n/a n/a
2021-11-12 2021-09-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM Call 18,300 446 n/a n/a n/a
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F ACADIA PHARMACEUTICALS COM Call 30,000 1,604 n/a n/a n/a
2020-05-14 2020-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F ACADIA PHARMACEUTICALS COM Call 10,000 0.00 428 19.22 n/a n/a n/a
2019-11-14 2019-09-30 13F ACADIA PHARMACEUTICALS COM Call 10,000 0.00 359 -16.12 n/a n/a n/a
2019-08-13 2019-06-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F ACADIA PHARMACEUTICALS COM Call 35,000 940 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM Put 220,000 1,000.00 4,897 817.04 n/a n/a n/a
2026-02-17 2025-12-31 13F ACADIA PHARMACEUTICALS COM Put 20,000 -88.66 534 -85.81 n/a n/a n/a
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM Put 176,300 487.67 3,762 481.45 n/a n/a n/a
2025-08-14 2025-06-30 13F ACADIA PHARMACEUTICALS COM Put 30,000 50.00 647 94.88 n/a n/a n/a
2025-05-15 2025-03-31 13F ACADIA PHARMACEUTICALS COM Put 20,000 332 n/a n/a n/a
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM Put 60,000 100.00 923 89.32 n/a n/a n/a
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM Put 30,000 -83.64 488 -85.64 n/a n/a n/a
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM Put 183,400 3,391 n/a n/a n/a
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ACADIA PHARMACEUTICALS COM Put 72,500 163.64 1,511 129.48 n/a n/a n/a
2023-08-14 2023-06-30 13F ACADIA PHARMACEUTICALS COM Put 27,500 659 n/a n/a n/a
2023-02-14 2022-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM Put 45,000 -30.77 738 -19.43 n/a n/a n/a
2022-08-15 2022-06-30 13F ACADIA PHARMACEUTICALS COM Put 65,000 -22.34 916 -54.83 n/a n/a n/a
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM Put 83,700 -29.49 2,028 -26.84 n/a n/a n/a
2022-02-11 2021-12-31 13F ACADIA PHARMACEUTICALS COM Put 118,700 2,772 n/a n/a n/a
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM Put 251,000 194.60 6,474 42.10 n/a n/a n/a
2021-02-16 2020-12-31 13F ACADIA PHARMACEUTICALS COM Put 85,200 54.35 4,556 100.09 n/a n/a n/a
2020-11-16 2020-09-30 13F ACADIA PHARMACEUTICALS COM Put 55,200 0.00 2,277 -14.88 n/a n/a n/a
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM Put 55,200 0.00 2,675 17.48 n/a n/a n/a
2020-05-14 2020-03-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F ACADIA PHARMACEUTICALS COM Put 80,000 33.33 3,424 58.67 n/a n/a n/a
2019-11-14 2019-09-30 13F ACADIA PHARMACEUTICALS COM Put 60,000 -53.09 2,158 -36.90 n/a n/a n/a
2019-08-13 2019-06-30 13F ACADIA PHARMACEUTICALS COM Put 127,900 265.43 3,420 263.83 n/a n/a n/a
2019-05-14 2019-03-31 13F ACADIA PHARMACEUTICALS COM Put 35,000 940 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.